HEADER LIGASE 11-JUN-07 2V31 TITLE STRUCTURE OF FIRST CATALYTIC CYSTEINE HALF-DOMAIN OF MOUSE UBIQUITIN- TITLE 2 ACTIVATING ENZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: UBIQUITIN-ACTIVATING ENZYME E1 X; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FIRST CATALYTIC CYSTEINE HALF-DOMAIN, RESIDUES 203-312; COMPND 5 SYNONYM: UBIQUITIN-ACTIVATING ENZYME E1, E1; COMPND 6 OTHER_DETAILS: TWO ADDITIONAL RESIDUES EF ON N-TERMINI SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090 KEYWDS LIGASE, PHOSPHORYLATION, CATALYTIC DOMAIN, HETERONUCLEAR NMR, FIRST KEYWDS 2 CATALYTIC CYSTEINE HALF-DOMAIN, E1 PROTEIN, ATP-BINDING, KEYWDS 3 UBIQUITINATION, NUCLEOTIDE-BINDING, UBL CONJUGATION PATHWAY EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.JAREMKO,M.JAREMKO,W.WOJCIECHOWSKI,R.FILIPEK,R.H.SZCZEPANOWSKI, AUTHOR 2 M.BOCHTLER,I.ZHUKOV REVDAT 4 24-OCT-18 2V31 1 REMARK REVDAT 3 24-JUL-13 2V31 1 REMARK VERSN DBREF SEQADV REVDAT 3 2 1 SCALE1 SCALE2 REVDAT 2 24-FEB-09 2V31 1 VERSN REVDAT 1 24-JUN-08 2V31 0 JRNL AUTH L.JAREMKO,M.JAREMKO,W.WOJCIECHOWSKI,R.FILIPEK, JRNL AUTH 2 R.H.SZCZEPANOWSKI,M.BOHTLER,I.ZHUKOV JRNL TITL STRUCTURE OF FIRST CATALYTIC CYSTEINE HALF-DOMAIN OF MOUSE JRNL TITL 2 UBIQUITIN-ACTIVATING ENZYME JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.JAREMKO,M.JAREMKO,R.FILIPEK,W.WOJCIECHOWSKI, REMARK 1 AUTH 2 R.H.SZCZEPANOWSKI,M.BOCHTLER,I.ZHUKOV REMARK 1 TITL NMR ASSIGNMENT OF STRUCTURALLY UNCHARACTERISED FRAGMENT OF REMARK 1 TITL 2 RECOMBINANT MOUSE UBIQUITIN-ACTIVATING ENZYME REMARK 1 REF J.BIOMOL.NMR V. 36 43 2006 REMARK 1 REFN ISSN 0925-2738 REMARK 1 PMID 16738783 REMARK 1 DOI 10.1007/S10858-006-9015-Z REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- REMARK 3 KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2V31 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1290032863. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 287.0 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITYPLUS REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SPARKY REMARK 210 METHOD USED : CYANA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 2 REMARK 210 REMARK 210 REMARK: NONE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 205 29.14 -152.83 REMARK 500 1 MET A 206 -175.72 57.67 REMARK 500 1 VAL A 207 34.31 -158.12 REMARK 500 1 SER A 211 -67.60 -130.46 REMARK 500 1 GLU A 214 179.86 60.35 REMARK 500 1 GLN A 215 160.12 60.01 REMARK 500 1 PRO A 216 174.11 -52.51 REMARK 500 1 ASP A 227 -161.43 -129.07 REMARK 500 1 ASN A 228 87.51 -152.49 REMARK 500 1 GLU A 237 44.85 -94.09 REMARK 500 1 THR A 244 94.70 -59.58 REMARK 500 1 ASP A 246 -178.36 -63.13 REMARK 500 1 SER A 251 -90.77 -99.97 REMARK 500 1 MET A 256 49.35 -93.04 REMARK 500 1 GLN A 258 -34.74 -39.33 REMARK 500 1 CYS A 262 30.53 -151.54 REMARK 500 1 GLN A 263 156.16 61.31 REMARK 500 1 CYS A 278 -177.53 -58.83 REMARK 500 1 ASN A 282 33.60 -96.06 REMARK 500 1 LYS A 296 68.68 -100.80 REMARK 500 1 LYS A 299 36.55 -154.52 REMARK 500 1 LEU A 310 -65.64 -99.33 REMARK 500 2 ASP A 227 -156.37 -106.32 REMARK 500 2 ASN A 228 89.52 -157.07 REMARK 500 2 THR A 244 91.57 -59.83 REMARK 500 2 SER A 251 -88.29 -105.00 REMARK 500 2 GLN A 258 -34.72 -38.94 REMARK 500 2 CYS A 278 -173.41 -58.51 REMARK 500 2 VAL A 297 136.14 65.14 REMARK 500 2 PRO A 298 97.53 -69.72 REMARK 500 2 SER A 302 117.74 62.26 REMARK 500 2 PHE A 303 33.05 -154.07 REMARK 500 2 LYS A 304 -70.90 -142.88 REMARK 500 2 SER A 305 33.26 -143.47 REMARK 500 2 LEU A 310 174.48 61.67 REMARK 500 3 PHE A 202 117.66 -161.37 REMARK 500 3 GLU A 204 -176.20 -63.27 REMARK 500 3 THR A 209 179.66 60.18 REMARK 500 3 SER A 211 90.77 60.67 REMARK 500 3 PRO A 216 -168.68 -73.12 REMARK 500 3 ASP A 227 -157.69 -127.76 REMARK 500 3 THR A 244 97.19 -57.86 REMARK 500 3 ASP A 246 -178.67 -64.90 REMARK 500 3 SER A 251 -94.09 -99.96 REMARK 500 3 GLN A 258 -34.71 -38.76 REMARK 500 3 CYS A 278 175.43 -57.31 REMARK 500 3 LYS A 296 77.95 -169.73 REMARK 500 3 VAL A 297 90.50 34.91 REMARK 500 3 LYS A 304 -75.41 -99.88 REMARK 500 3 LEU A 306 91.08 59.10 REMARK 500 REMARK 500 THIS ENTRY HAS 400 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z7L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FRAGMENT OF MOUSE UBIQUITIN-ACTIVATINGENZYME REMARK 900 RELATED ID: 7053 RELATED DB: BMRB REMARK 999 REMARK 999 SEQUENCE REMARK 999 EXTRA EF ON N-TERMINI DBREF 2V31 A 203 312 UNP Q02053 UBE1X_MOUSE 203 312 SEQADV 2V31 GLU A 201 UNP Q02053 EXPRESSION TAG SEQRES 1 A 112 GLU PHE GLY GLU GLU MET VAL LEU THR ASP SER ASN GLY SEQRES 2 A 112 GLU GLN PRO LEU SER ALA MET VAL SER MET VAL THR LYS SEQRES 3 A 112 ASP ASN PRO GLY VAL VAL THR CYS LEU ASP GLU ALA ARG SEQRES 4 A 112 HIS GLY PHE GLU THR GLY ASP PHE VAL SER PHE SER GLU SEQRES 5 A 112 VAL GLN GLY MET ILE GLN LEU ASN GLY CYS GLN PRO MET SEQRES 6 A 112 GLU ILE LYS VAL LEU GLY PRO TYR THR PHE SER ILE CYS SEQRES 7 A 112 ASP THR SER ASN PHE SER ASP TYR ILE ARG GLY GLY ILE SEQRES 8 A 112 VAL SER GLN VAL LYS VAL PRO LYS LYS ILE SER PHE LYS SEQRES 9 A 112 SER LEU PRO ALA SER LEU VAL GLU HELIX 1 1 ASN A 260 CYS A 262 5 3 SHEET 1 AA 6 SER A 218 VAL A 224 0 SHEET 2 AA 6 ILE A 291 VAL A 295 -1 O GLN A 294 N ALA A 219 SHEET 3 AA 6 PHE A 247 PHE A 250 -1 O SER A 249 N SER A 293 SHEET 4 AA 6 MET A 265 VAL A 269 -1 O MET A 265 N VAL A 248 SHEET 5 AA 6 THR A 274 ILE A 277 -1 O SER A 276 N LYS A 268 SHEET 6 AA 6 VAL A 231 CYS A 234 -1 O GLY A 230 N ILE A 277 SHEET 7 AA 6 SER A 218 VAL A 224 -1 N SER A 222 O THR A 233 CISPEP 1 ASN A 228 PRO A 229 1 -0.20 CISPEP 2 ASN A 228 PRO A 229 2 -0.27 CISPEP 3 ASN A 228 PRO A 229 3 -0.27 CISPEP 4 ASN A 228 PRO A 229 4 -0.25 CISPEP 5 ASN A 228 PRO A 229 5 0.17 CISPEP 6 ASN A 228 PRO A 229 6 -0.27 CISPEP 7 ASN A 228 PRO A 229 7 -0.18 CISPEP 8 ASN A 228 PRO A 229 8 -0.25 CISPEP 9 ASN A 228 PRO A 229 9 -0.16 CISPEP 10 ASN A 228 PRO A 229 10 -0.11 CISPEP 11 ASN A 228 PRO A 229 11 -0.10 CISPEP 12 ASN A 228 PRO A 229 12 -0.13 CISPEP 13 ASN A 228 PRO A 229 13 -0.26 CISPEP 14 ASN A 228 PRO A 229 14 -0.08 CISPEP 15 ASN A 228 PRO A 229 15 -0.16 CISPEP 16 ASN A 228 PRO A 229 16 -0.14 CISPEP 17 ASN A 228 PRO A 229 17 -0.18 CISPEP 18 ASN A 228 PRO A 229 18 -0.14 CISPEP 19 ASN A 228 PRO A 229 19 -0.28 CISPEP 20 ASN A 228 PRO A 229 20 -0.15 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 159 0 0 1 7 0 0 6 0 0 0 9 END